The Role of Dipeptidyl Peptidase 4 as a Therapeutic Target and Serum Biomarker in Inflammatory Bowel Disease: A Systematic Review.

Francisco Jorge MeloPedro Pinto-LopesMaria Manuela EstevinhoFernando Magro

Published in: Inflammatory bowel diseases (2022)

The use of DPP4 inhibitors and analogs of its substrates has clear benefits in the treatment of experimentally induced intestinal inflammation. Further research is warranted to validate their potential diagnostic and therapeutic applications in IBD patients.

Keyphrases

ejection fraction
newly diagnosed
oxidative stress
prognostic factors
high glucose
diabetic rats
patient reported outcomes
endothelial cells
ulcerative colitis
replacement therapy
stress induced